Literature DB >> 23681423

MiR-17-92 cluster: an apoptosis inducer or proliferation enhancer.

Najmeh Ranji1, Majid Sadeghizadeh, Mohammad Ali Shokrgozar, Behnaz Bakhshandeh, Morteza Karimipour, Amir Amanzadeh, Keyhan Azadmanesh.   

Abstract

Study of the non-coding RNA roles in the regulation of adaptive immune responses through T cells could be the basis of novel therapeutic applications. MicroRNAs (miRNAs) are a class of short non-coding RNAs that control the cell's functions and destination. To investigate the role of miRNAs in T cell activation, herein the expressions of miR-17-92 cluster and its paralogs were studied in naïve CD4(+)T cells that were activated by anti-CD2, -CD3, -CD28 microbeads and induced with or without IL-2. Proliferation and apoptosis rate of the cultured cells were determined by BrdU incorporation assay (ELISA) and propidium iodide staining, respectively. In continuation the expressions of eight miRNAs of the mentioned clusters were analyzed quantitatively. In addition their potential targets were predicted using multiple algorithms; as a confirmation, the transcription of PIK3R3 (a putative target of modulated miRNAs) was evaluated. Stimulation index (SI) of activated cells was decreased on day 6; whereas, the IL-2 induced cells showed increase in SI in the assay time. Evaluation of eight members of the aforementioned cluster showed upregulation of miR-92a-2* (~15 times) in IL-2 un-induced (activated) cells relative to the IL-2 induced cells. In silico investigations revealed that the suggested miRNAs targeted genes that were involved in cell proliferation, survival, and apoptosis. Transcriptional analysis of PIK3R3 illustrated decrease in activated cells relative to IL-2 induced cells. According to our findings, it seems that multiple members of miR-17-92 families in activated CD4(+)T cells inhibited negative regulators of IL-2 such as DUSP, PTPN, and SOCS families after IL-2 induction. According to our findings, it seems that multiple genes of cell proliferation-related families such as MAPK, E2F, AKT, STAT, and JAK as well as PIK3R3 are inhibited by miR-17-92 cluster in activated cells. As FASL is a putative target of over-expressed miRNAs in activated cell, antigen-induced cell death (AICD) might be occurred in FASL-independent manner. Altogether this study suggested that clonal expansion through IL-2 signaling pathway does not depend on the members of miR-17-92 family; while, it appears that AICD in activated CD4(+)T cells without IL-2 induction is affected by these miRNA clusters.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23681423     DOI: 10.1007/s11010-013-1678-7

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  52 in total

Review 1.  It's all Rel-ative: NF-kappaB and CD28 costimulation of T-cell activation.

Authors:  Lawrence P Kane; Joseph Lin; Arthur Weiss
Journal:  Trends Immunol       Date:  2002-08       Impact factor: 16.687

2.  MicroRNA signature associated with osteogenic lineage commitment.

Authors:  Behnaz Bakhshandeh; Masoud Soleimani; Maryam Hafizi; Seyed Hassan Paylakhi; Nasser Ghaemi
Journal:  Mol Biol Rep       Date:  2012-02-16       Impact factor: 2.316

3.  Induction of IL-1 beta-converting enzyme-independent apoptosis by IL-2 in human T cell lines.

Authors:  K Oda; H Asao; M Higuchi; N Tanaka; S Moffatt; M Nakamura; K Tabayashi; K Sugamura
Journal:  Int Immunol       Date:  1997-09       Impact factor: 4.823

4.  A microRNA signature associated with chondrogenic lineage commitment.

Authors:  Behnaz Bakhshandeh; Masoud Soleimani; Seyed Hassan Paylakhi; Nasser Ghaemi
Journal:  J Genet       Date:  2012-08       Impact factor: 1.166

5.  Induction of PP2A Bβ, a regulator of IL-2 deprivation-induced T-cell apoptosis, is deficient in systemic lupus erythematosus.

Authors:  José C Crispín; Sokratis A Apostolidis; Melissa I Finnell; George C Tsokos
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-11       Impact factor: 11.205

6.  JAB/SOCS1/SSI-1 is an interleukin-2-induced inhibitor of IL-2 signaling.

Authors:  B Sporri; P E Kovanen; A Sasaki; A Yoshimura; W J Leonard
Journal:  Blood       Date:  2001-01-01       Impact factor: 22.113

7.  Human activated CD4(+) T lymphocytes increase IL-2 expression by downregulating microRNA-181c.

Authors:  Qian Xue; Zhang-Yan Guo; Wei Li; Wei-Hong Wen; Yan-Ling Meng; Lin-Tao Jia; Jian Wang; Li-Bo Yao; Bo-Quan Jin; Tao Wang; An-Gang Yang
Journal:  Mol Immunol       Date:  2010-11-26       Impact factor: 4.407

8.  Comparison of gene expression profiles in mouse primary T cells under normal and prolonged activation.

Authors:  Luan Shu; Wu Yin; Hongqin Zhuang; Zichun Hua
Journal:  Blood Cells Mol Dis       Date:  2006-06-05       Impact factor: 3.039

9.  c-Myc-regulated microRNAs modulate E2F1 expression.

Authors:  Kathryn A O'Donnell; Erik A Wentzel; Karen I Zeller; Chi V Dang; Joshua T Mendell
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

10.  MiR-17-92 cluster is associated with 13q gain and c-myc expression during colorectal adenoma to adenocarcinoma progression.

Authors:  B Diosdado; M A van de Wiel; J S Terhaar Sive Droste; S Mongera; C Postma; W J H J Meijerink; B Carvalho; G A Meijer
Journal:  Br J Cancer       Date:  2009-08-18       Impact factor: 7.640

View more
  13 in total

1.  Circulating MicroRNA Are Predictive of Aging and Acute Adaptive Response to Resistance Exercise in Men.

Authors:  Lee M Margolis; Sarah J Lessard; Yassine Ezzyat; Roger A Fielding; Donato A Rivas
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2017-10-01       Impact factor: 6.053

2.  Effects of miR-21 downregulation and silibinin treatment in breast cancer cell lines.

Authors:  Zohreh Jahanafrooz; Nasrin Motamed; Behnaz Bakhshandeh
Journal:  Cytotechnology       Date:  2017-03-20       Impact factor: 2.058

3.  MicroRNA-17~92 is required for nephrogenesis and renal function.

Authors:  April K Marrone; Donna B Stolz; Sheldon I Bastacky; Dennis Kostka; Andrew J Bodnar; Jacqueline Ho
Journal:  J Am Soc Nephrol       Date:  2014-02-07       Impact factor: 10.121

Review 4.  Potential Role of MicroRNA in the Anabolic Capacity of Skeletal Muscle With Aging.

Authors:  Lee M Margolis; Donato A Rivas
Journal:  Exerc Sport Sci Rev       Date:  2018-04       Impact factor: 6.230

5.  AKT family and miRNAs expression in IL-2 induced CD4(+)T cells.

Authors:  Najmeh Ranji; Majid Sadeghizadeh; Morteza Karimipoor; Mohammad Ali Shokrgozar; Reza Ebrahimzadeh-Vesal
Journal:  Iran J Basic Med Sci       Date:  2014-11       Impact factor: 2.699

6.  Circulating MiR-16-5p and MiR-19b-3p as Two Novel Potential Biomarkers to Indicate Progression of Gastric Cancer.

Authors:  Jingpu Zhang; Yang Song; Chunlei Zhang; Xiao Zhi; Hualin Fu; Yue Ma; Yunsheng Chen; Fei Pan; Kan Wang; Jian Ni; Weilin Jin; Xianli He; Haichuan Su; Daxiang Cui
Journal:  Theranostics       Date:  2015-04-05       Impact factor: 11.556

7.  Deregulation of miR-21 and miR-155 and their putative targets after silibinin treatment in T47D breast cancer cells.

Authors:  Masoud Maleki Zadeh; Najmeh Ranji; Nasrin Motamed
Journal:  Iran J Basic Med Sci       Date:  2015-12       Impact factor: 2.699

8.  Differential Sensitivity of Target Genes to Translational Repression by miR-17~92.

Authors:  Hyun Yong Jin; Hiroyo Oda; Pengda Chen; Chao Yang; Xiaojuan Zhou; Seung Goo Kang; Elizabeth Valentine; Jennifer M Kefauver; Lujian Liao; Yaoyang Zhang; Alicia Gonzalez-Martin; Jovan Shepherd; Gareth J Morgan; Tony S Mondala; Steven R Head; Pyeung-Hyeun Kim; Nengming Xiao; Guo Fu; Wen-Hsien Liu; Jiahuai Han; James R Williamson; Changchun Xiao
Journal:  PLoS Genet       Date:  2017-02-27       Impact factor: 5.917

9.  Silibinin-Induced Apoptosis and Downregulation of MicroRNA-21 and MicroRNA-155 in MCF-7 Human Breast Cancer Cells.

Authors:  Masoud Maleki Zadeh; Nasrin Motamed; Najmeh Ranji; Mohammad Majidi; Fahimeh Falahi
Journal:  J Breast Cancer       Date:  2016-03-25       Impact factor: 3.588

10.  MicroRNA-421-targeted PDCD4 regulates breast cancer cell proliferation.

Authors:  Yiwei Wang; Zipeng Liu; Jian Shen
Journal:  Int J Mol Med       Date:  2018-10-15       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.